Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
0.7600
-0.0401 (-5.01%)
At close: Apr 1, 2025, 4:00 PM
0.7590
-0.0010 (-0.13%)
After-hours: Apr 1, 2025, 4:47 PM EDT
Milestone Pharmaceuticals Stock Forecast
MIST's stock price has decreased by -57.79% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Milestone Pharmaceuticals stock have an average target of 9.50, with a low estimate of 9.00 and a high estimate of 10. The average target predicts an increase of 1,150.00% from the current stock price of 0.76.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Milestone Pharmaceuticals stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $10 | Strong Buy | Maintains | $25 → $10 | +1,215.79% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +3,189.47% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +3,189.47% | Mar 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +3,189.47% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +3,189.47% | Jan 27, 2025 |
Financial Forecast
Revenue This Year
6.43M
Revenue Next Year
39.51M
from 6.43M
Increased by 514.81%
EPS This Year
-1.30
from -0.67
EPS Next Year
-1.42
from -1.30
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.0M | 63.0M | 188.6M | ||
| Avg | 6.4M | 39.5M | 158.7M | ||
| Low | 4.9M | 5.2M | 128.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 880.4% | 377.3% | ||
| Avg | - | 514.8% | 301.6% | ||
| Low | - | -19.2% | 226.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.07 | -0.93 | -0.02 | ||
| Avg | -1.30 | -1.42 | -0.82 | ||
| Low | -1.50 | -1.85 | -1.55 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.